Scandinavian ChemoTech AB Series B Strategic Asset Allocation Index
Scandinavian ChemoTech AB Series B strategic asset allocation index. Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Strategic Asset Allocation Index of 3.7% as of December 2025. Strategic assets (PP&E of Skr119.00K plus long-term investments of Skr-) total Skr119.00K, measured against net assets of Skr3.19 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Scandinavian ChemoTech AB Series B's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Scandinavian ChemoTech AB Series B (2017–2025)
Strategic asset allocation index of Scandinavian ChemoTech AB Series B from 2017 to 2025. This chart shows how Scandinavian ChemoTech AB Series B's Strategic Asset Allocation Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 3.7%, representing strategic assets of Skr119.00K against net assets of Skr3.19 Million SEK. Check CMOTEC-B tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Scandinavian ChemoTech AB Series B Strategic Asset Allocation Index by Year (2017–2025)
Scandinavian ChemoTech AB Series B strategic asset allocation index by year from 2017 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Scandinavian ChemoTech AB Series B from 2017 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CMOTEC-B stock market capitalisation.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.7% | Skr119.00K | Skr119.00K | Skr- | Skr3.19 Million | ▲ +3.7 pp |
| 2024 | 0.1% | Skr4.00K | Skr4.00K | Skr- | Skr5.98 Million | ▼ 0.0 pp |
| 2023 | 0.1% | Skr12.00K | Skr12.00K | Skr- | Skr11.03 Million | ▼ -0.1 pp |
| 2022 | 0.3% | Skr35.00K | Skr35.00K | Skr- | Skr13.99 Million | ▼ -0.1 pp |
| 2021 | 0.3% | Skr73.00K | Skr73.00K | Skr- | Skr23.92 Million | ▼ -0.4 pp |
| 2020 | 0.7% | Skr62.00K | Skr62.00K | Skr- | Skr9.24 Million | ▼ -0.2 pp |
| 2019 | 0.9% | Skr87.00K | Skr87.00K | Skr- | Skr9.73 Million | ▲ +0.5 pp |
| 2018 | 0.4% | Skr79.00K | Skr79.00K | Skr- | Skr20.50 Million | ▼ -0.9 pp |
| 2017 | 1.3% | Skr129.00K | Skr129.00K | Skr- | Skr10.29 Million | — |